Abstract
Malignant hyperthermia is an autosomal dominant inherited disease characterized by a hypermetabolic response, with an exaggerated release of calcium from the sarcoplasmic reticulum, which can be triggered in the perioperative period by exposure to volatile anesthetics (halothane, isoflurane, sevoflurane and desflurane) and neuromuscular blockers. depolarizing (succinylcholine) life-threatening condition in 80% without the availability of dantrolene. However, the incidence of recrudescence is close to 20%, a rare and infrequent scenario, which the anesthesiologist managing a suspected case must consider guaranteeing critical monitoring for at least the next 24 hours.
| Translated title of the contribution | Recrudescence of malignant hyperthermia: be ready for a second round: a case report |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 532-535 |
| Number of pages | 4 |
| Journal | Revista Chilena de Anestesia |
| Volume | 53 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1 Sep 2024 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Recrudescence of malignant hyperthermia: be ready for a second round: a case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver